|
|||||
|
|
Risk factors for mortality in users of ibopamine |
|
| Authors: | J. Feenstra,B. A. in''t Veld,P. D. van der Linden,D. E. Grobbee,& B. H. Ch. Stricker |
| Affiliation: | Drug Safety Unit, Inspectorate for Health Care, Rijswijk,;Pharmaco-epidemiology Unit, Department of Epidemiology and Biostatistics, Erasmus University Medical School, Rotterdam,;Julius Center for Patient Oriented Research, Utrecht University Medical School, The Netherlands |
| Abstract: | |
| Keywords: | ibopamine mortality risk factors |